Anterior Actions
Modular AI tasks that apply to any health plan workflow
Company profile
Company profile
Anterior is a healthcare AI company that accelerates digital transformation for health plans by deploying clinically accurate AI solutions for administrative workflows. The company specializes in prior authorization automation, offering an end-to-end solution that achieves 99.24% clinical accuracy as verified by KLAS. Anterior's platform is built on modular AI tasks called 'Actions' that can be configured into complete workflow solutions, enabling health plans to move from proof of concept to measurable results. The technology integrates directly into existing technology stacks and is designed to be transparent, auditable, and configurable at every step. Anterior's prior authorization solution covers the complete workflow from case intake and verification through clinical reasoning and decision summarization, with real-time decisioning capabilities at the point of care. The platform is designed with an affirmative decision-making approach, evaluating all clinical pathways for approval while escalating complex cases to clinicians for review. With 90% accuracy out of the box and FHIR-compliant policy digitization, Anterior helps health plans achieve significant operational improvements including 85% reduction in baseline administrative costs, 76% increase in auto-approvals, and 56% reduction in staff burden time. The company recently raised $64M in total funding to accelerate AI adoption across the health plan industry.
Company description Anterior official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
No clinical focus areas are currently listed.
Cloud Saas deployment with recorded integration context.
Recorded integration context: EMR systems, Existing health plan technology stacks, FHIR-compliant systems.
Company milestones
Raised $64M in total funding to accelerate health plan AI adoption, achieved KLAS verification of 99.24% clinical accuracy, deployed solution processing 6M prior authorizations annually for large payer enterprise
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Modular AI tasks that apply to any health plan workflow
Enterprise-grade AI for automated prior authorization with 99.24% clinical accuracy
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Ophthalmic genetics · Sep 3, 2026
Repositioning of Vertical Implantable Phakic Contact Lens.Clinical case reports · Sep 1, 2026
Visual and Refractive Outcomes of Corneal Refractive Surgery for Hyperopic and Mixed Astigmatism: A Systematic Review and Meta-Analysis.Seminars in ophthalmology · Aug 29, 2026
Primary intervention with hypermetropic spectacles: Factors influencing improvement in esotropia.Indian journal of ophthalmology · Aug 24, 2026
Central Compartment Atopic Disease Within the Chronic Upper Airway Inflammatory Continuum: A Scoping Review of Sinonasal Compartmentalization and Type-2 Airway Disease.Current allergy and asthma reports · Aug 20, 2026
Eye banking in India: Present status, goals, and prospects for a future-ready ecosystem.The Indian journal of medical research · Aug 1, 2026
Clinical validation
NCT07292298 · Mentioned · RECRUITING
Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal ResectionsNCT07351071 · Mentioned · RECRUITING
Study of Artelon FLEXBAND® for Patients Undergoing Soft Tissue Reconstruction of the Anterior Talofibular Ligament (ATFL) to Treat Lateral Ankle InstabilityNCT06638138 · Mentioned · COMPLETED
Effects of Rapid-Resisted Exercise and Bright Light Therapy on Ambulatory Adults With Traumatic Brain InjuryNCT01175993 · Mentioned · COMPLETED
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCLNCT06500273 · Mentioned · RECRUITING
Machine Learning-based Surgical Guidance System for Robot-assisted Rectal SurgeryNCT05652361 · Mentioned · RECRUITING
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Administrative cost reduction
Staff efficiency improvement
KLAS-verified accuracy
Prior authorization automation
Speed of decision-making
Baseline performance before customization
Clinician satisfaction in case study
Transformed prior authorization workflows to reduce administrative burden and improve clinical accuracy
6M prior authorizations per year processed with 99.24% clinical accuracy (KLAS-verified) and 92 clinician CSAT score
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on Anterior's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies using AI to optimize hospital operations, automate administrative workflows, improve scheduling, manage healthcare resources, coordinate care delivery, or reduce operational inefficiencies. Includes prior authorization automation, credentialing, billing, care coordination, and AI tools that help health systems run more efficiently.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.